Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 10:45 PM
Study NCT ID:
NCT01266967
Status:
COMPLETED
Last Update Posted:
2014-05-08
First Post:
2010-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-02
First Submit QC Date:
None
Study First Post Date:
2010-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-06-24
Results First Submit QC Date:
None
Results First Post Date:
2014-03-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-06-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-04-24
Last Update Post Date:
2014-05-08
Last Update Post Date Type:
ESTIMATED